New York, Dec. 15 – JPMorgan Chase Financial Co. LLC priced $1 million of 0% capped dual directional buffered equity notes due Jan. 16, 2025 linked to the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.
If the ETF gains the payout will be par plus the ETF return capped at par plus 15.1%.
The payout will be par plus 100% of the absolute value of the ETF return if the ETF declines but by no more than the 15% buffer.
Investors will lose 1% for every 1% that the ETF declines beyond the buffer.
The securities are non-callable.
The notes are guaranteed by JPMorgan Chase & Co.
J.P. Morgan Securities LLC is the agent.
| Issuer: | JPMorgan Chase Financial Co. LLC
|
| Guarantor: | JPMorgan Chase & Co.
|
| Issue: | Capped dual directional buffered equity notes
|
| Underlying ETF: | SPDR S&P Biotech ETF
|
| Amount: | $1 million
|
| Maturity: | Jan. 16, 2025
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | If ETF gains par plus ETF return capped at par plus 15.1%; par plus 100% of absolute value of ETF return if ETF declines but by no more than 15% buffer; 1% loss for every 1% that ETF declines beyond the buffer
|
| Call: | Non-callable
|
| Initial level: | $80.08
|
| Cap: | 15.1%
|
| Buffer: | 15%
|
| Pricing date: | Dec. 12
|
| Settlement date: | Dec. 15
|
| Agent: | J.P. Morgan Securities LLC
|
| Fees: | 2.225%
|
| Cusip: | 48134RV54
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
